Chlormezanone

From Self-sufficiency
Revision as of 21:12, 16 September 2010 by Carlo Banez (Talk) (Adding category Category:Withdrawn drugs (using HotCat))

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
Chlormezanone
File:Chlormezanone.svg
Systematic (IUPAC) name
2-(4-chlorophenyl)-3-methyl-1,1-dioxo-1,3-thiazinan-4-one
Clinical data
Routes of
administration
Oral
Legal status
Legal status
  • ℞ (Prescription only)
Pharmacokinetic data
Biological half-life 40.5 hours
Identifiers
CAS Number 80-77-3
ATC code M03BB02 (WHO)
PubChem CID 2717
DrugBank APRD00865
ChemSpider 2616
Chemical data
Formula C11H12ClNO3S
Molar mass 273.737 g/mol[[Script error: No such module "String".]]
Script error: No such module "collapsible list".
  (verify)
Script error: No such module "TemplatePar".Expression error: Unexpected < operator.

Chlormezanone (marketed under the brandname Trancopal) is a drug used as an anxiolytic and a muscle relaxant.

Its use was discontinued in many countries in 1996, due to rare but serious cases of toxic epidermal necrolysis.

References

  • Wollina U, Hipler U, Seeling A, Oelschlager H (2005). "Investigations of interactions of chlormezanone racemate and its enantiomers on human keratinocytes and human leucoytes in vitro". Skin Pharmacol Physiol. 18 (3): 132–8. doi:10.1159/000084910. PMID 15897685. 
  • Seeling A, Oelschläger H, Rothley D (2000). "Important pharmaceutical-chemical characteristics of the central muscle relaxant chlormezanone". Pharmazie. 55 (4): 293–6. PMID 10798243. 
  • Oelschläger H, Klinger W, Rothley D, Seeling A, Bockhard H, Hofmann B, Machts H, Riederer H, Rackur H (1998). "[Cleavage and biotransformation of the central muscle relaxant chlormezanone]". Pharmazie. 53 (9): 620–4. PMID 9770210. 
  • Gautier V, Vincon G, Demotes-Mainard F, Albin H (1990). "[Pharmacokinetics of chlormezanone in healthy volunteers] (original in French)". Pharmazie. 45 (4): 315–9. PMID 2399514. 



sv:Klormezanon